China, Oct. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A methodological study on the assessment of the risk of ABO and RhD blood type system-related HDFN through the detection of fetal free DNA in the peripheral blood of pregnant women'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134177
Registration Time: 2026/10/12
Type: Diagnostic test
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=315725
Published by HT Digital Content Services with permission from Health Daily Digest....